Growth in India’s Bioeconomy Sector

Growth in India’s Bioeconomy Sector: Institutional Analysis and Challenges

The growth of India’s bioeconomy reflects the convergence of biotechnology innovation and sustainable economic frameworks. At its core, the bioeconomy is a knowledge-based paradigm integrating biological resources with economic outcomes. The tension between rapid biotechnological commercialisation and sustainability-driven innovation defines this sector. Equipped with a 13-fold growth in a decade (2014–2024), India’s bioeconomy is poised to contribute significantly to GDP and employment but faces structural challenges in R&D, infrastructure, and global competitiveness.

UPSC Relevance Snapshot

• GS Paper III: Economy – Role of biotechnology, industrial growth, employment trends.
• GS Paper III: Science & Technology – Developments in biotechnology and its application.
• Essay: Themes on sustainable innovation or knowledge economy in India.

Institutional Framework: Foundation of India’s Bioeconomy

India's bioeconomy operates through a structured multi-institutional framework encompassing government initiatives, private investments, and academic research. The Department of Biotechnology (DBT) and allied institutions like BIRAC (Biotechnology Industry Research Assistance Council) drive innovation and strategic research. This growth is supported by conducive policies such as the Draft R&D Policy 2021 and Production Linked Incentive (PLI) schemes.

• Key Institutions:
  • Department of Biotechnology (DBT): Oversees policy formulation, R&D facilitation.
  • BIRAC: Funds start-ups, promotes biotech enterprises for scalable innovation.
  • Indian Institute of Science (IISc) and IITs: Academic hubs for fundamental research.
• Policies and Programs:
  • Make in India: Developing domestic biotech manufacturing capabilities.
  • Startup India: Supporting early-stage biotech innovators.
  • PLI Schemes: Offer financial incentives for domestic manufacturing and R&D expansion.
• Funding: Combination of public grants, tax incentives, and venture capital investment focused on biotech-driven GDP growth.

Key Issues and Challenges

Infrastructure and Research Ecosystem

• Insufficient advanced research facilities for bio-manufacturing comparable to the US and EU.
• Absence of integrated innovation clusters to link academia, industry, and start-ups.

Global Competitiveness

• India ranks 12th worldwide in biomanufacturing (Global Innovation Index) but lags in fundamental R&D expenditure (0.7% of GDP against the global average of ~2.5%).
• Competes with established players (USA, EU, and China) which possess superior funding and workforce ecosystems.

Intellectual Property (IP) Bottlenecks

• Weak IP protection frameworks lead to reluctance in commercialising cutting-edge biotech research.
• Lengthy patenting processes limit market responsiveness of indigenous innovations.

Human Capital and Brain Drain

• Lack of competitive career opportunities drives migration of skilled biotech professionals abroad.
• Mismatch between academic training and industry requirements hampers high-quality manpower development.

Comparative Analysis: India vs USA in Bioeconomy

Critical Evaluation

The bioeconomy in India, while promising, is constrained by deficits in funding, infrastructure, and workforce retention. With only 0.7% of its GDP dedicated to R&D, India lags behind global leaders like the USA and Germany in innovation. Although initiatives like BIRAC and PLI schemes have accelerated gains, the sector remains vulnerable to high capital costs and external competition. Furthermore, the absence of strong intellectual property frameworks discourages investment in high-value biotech innovations. Bridging the human capital gap and building synergies between industry, academia, and government constitute prerequisites for sustained growth.

Structured Assessment

• Policy Design Adequacy: Programs such as BIRAC and the PLI schemes provide a robust policy ecosystem. However, policy execution lacks alignment across states and institutions.
• Governance and Institutional Capacity: While central-level institutional initiatives exist, challenges emerge from inadequate funding, fragmented infrastructure, and weak enforcement of IP norms.
• Behavioural and Structural Bottlenecks: Talent migration and a lack of entrepreneurial mindset hinder India’s competitiveness in global bioeconomy markets.

Frequently Asked Questions